In general, entrepreneurship is such a risky game, and requires a lot of grit and courage. Those who win end up getting all of the cake, but those who fail will get more than nothing, because of the possibility of accumulated debt. Fortunately for people like Eric Lefkofksy and his company Tempus Labs, he’s able to withstand such challenges and still emerge thriving, relevant and profitable.
The Chicago Power
What probably made Tempus Labs one of the successful companies today is because it’s based in Chicago, a state where it’s conducive to start any type of business. Being one of the most influential companies in Chicago also means that Tempus Labs already has the roots to be outstanding and for people to trust more its products. This success might also be because the services offered in Tempus Labs are some of the most relevant and in-demand services today that many people will pay money for, which include cancer testing, sequencing of patients’ tumors and liquid biopsy of cell-free DNA. All of these programs are remarkably in-demand and almost necessary for people, and it’s such a clever move for Mr. Eric to capitalize on this.
Mr. Lefkosky is the co-founder of Tempus Labs, and his direct involvement in the company’s operations makes him more hands-on in its results and directives. For this reason, he makes sure that the testing he offers are just about right in its price points, giving more people access to necessary but otherwise expensive tests.
About Eric Lefkofsky
Eric is mainly known to be head officer and co-founder of Tempus Labs, a tech and health tests company that operates mainly to help battle cancer. The disruptive technologies today have a lot of potentials to help people undergoing cancer treatments or have loved ones who do, and Eric is mainly leveraging all these technologies to make sure that people can get the right methods, tools, data, and assistance they need.
Mr. Lefkofsky is also famous for being the adjunct professor at the University of Chicago, and the book about Accelerated Disruption that he authored remains to be a well referenced resource in modern health tech.
To Learn More Click Here